Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.
2.

Parent-mediated early intervention for young children with autism spectrum disorders (ASD).

Oono IP, Honey EJ, McConachie H.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009774. doi: 10.1002/14651858.CD009774.pub2. Review.

PMID:
23633377
3.

[Empirically based early intervention programs for children with autistic disorders - a selective literature review].

Freitag CM.

Z Kinder Jugendpsychiatr Psychother. 2010 Jul;38(4):247-56. doi: 10.1024/1422-4917/a000043. Review. German.

PMID:
20617494
4.

A systematic review of early intensive intervention for autism spectrum disorders.

Warren Z, McPheeters ML, Sathe N, Foss-Feig JH, Glasser A, Veenstra-Vanderweele J.

Pediatrics. 2011 May;127(5):e1303-11. doi: 10.1542/peds.2011-0426. Epub 2011 Apr 4. Review.

PMID:
21464190
5.

[Pharmacological treatments in patients with pervasive developmental disorders: A review].

Béhérec L, Quilici G, Rosier A, Gerardin P, Campion D, Guillin O.

Encephale. 2014 Apr;40(2):188-96. doi: 10.1016/j.encep.2012.01.014. Epub 2013 Dec 23. Review. French.

PMID:
24369879
6.

Access to treatment for toddlers with autism spectrum disorders.

Braddock B, Twyman K.

Clin Pediatr (Phila). 2014 Mar;53(3):225-9. doi: 10.1177/0009922814521284. Epub 2014 Jan 24. Review.

PMID:
24463947
7.

Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD).

Reichow B, Barton EE, Boyd BA, Hume K.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD009260. doi: 10.1002/14651858.CD009260.pub2. Review.

PMID:
23076956
8.

mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders.

Oberman LM.

Expert Opin Investig Drugs. 2012 Dec;21(12):1819-25. doi: 10.1517/13543784.2012.729819. Epub 2012 Sep 26. Review.

PMID:
23013434
9.

Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review.

Ospina MB, Krebs Seida J, Clark B, Karkhaneh M, Hartling L, Tjosvold L, Vandermeer B, Smith V.

PLoS One. 2008;3(11):e3755. doi: 10.1371/journal.pone.0003755. Epub 2008 Nov 18. Review.

10.

Social skills development in children with autism spectrum disorders: a review of the intervention research.

Williams White S, Keonig K, Scahill L.

J Autism Dev Disord. 2007 Nov;37(10):1858-68. Epub 2006 Dec 29. Review.

PMID:
17195104
11.

[Clinical features in autism].

Robel L.

Arch Pediatr. 2009 Nov;16(11):1507-12. doi: 10.1016/j.arcped.2009.07.018. Epub 2009 Sep 3. Review. French.

PMID:
19733037
12.

Pharmacological treatment options for autism spectrum disorders in children and adolescents.

Leskovec TJ, Rowles BM, Findling RL.

Harv Rev Psychiatry. 2008;16(2):97-112. doi: 10.1080/10673220802075852. Review.

PMID:
18415882
13.

Care of the patient with an autism spectrum disorder by the general physician.

Venkat A, Jauch E, Russell WS, Crist CR, Farrell R.

Postgrad Med J. 2012 Aug;88(1042):472-81. doi: 10.1136/postgradmedj-2011-130727. Epub 2012 Mar 16. Review.

PMID:
22427366
14.

New directions in the treatment of autism spectrum disorders from animal model research.

Chadman KK, Guariglia SR, Yoo JH.

Expert Opin Drug Discov. 2012 May;7(5):407-16. doi: 10.1517/17460441.2012.678828. Epub 2012 Apr 12. Review.

PMID:
22494457
15.

Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.

Spooren WP, Gasparini F, Salt TE, Kuhn R.

Trends Pharmacol Sci. 2001 Jul;22(7):331-7. Review.

PMID:
11431019
16.

In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article.

Kuhn R, Pagano A, Stoehr N, Vranesic I, Flor PJ, Lingenhöhl K, Spooren W, Gentsch C, Vassout A, Pilc A, Gasparini F.

Amino Acids. 2002;23(1-3):207-11. Review.

PMID:
12373539

Supplemental Content

Support Center